The Effect of Swallowing Training for Elderly People in the Community
Launched by ZENG CHANGHAO · Dec 31, 2023
Trial Information
Current as of June 26, 2025
Withdrawn
Keywords
ClinConnect Summary
The investigators have designed a simple and user-friendly swallowing rehabilitation training method called "systematic simple swallowing training" based on commonly used swallowing training techniques in the department of rehabilitation medicine and the prevalent pathological causes of swallowing disorders in the elderly. It has shown promising preliminary efficacy. However, before we can promote its widespread adoption, a series of studies must be conducted to establish its effectiveness. The goal of this clinical trial is to explore the impact of systematic simple swallowing training on ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age over 60 years old.
- • No hospitalization within the past six months.
- • With clear consciousness and able to cooperate with questionnaires and training.
- • The elderly people who voluntarily participate and agree to adhere until the end of the study.
- Exclusion Criteria:
- • Complicated with severe liver and kidney failure, tumors, or hematological disorders.
- • Physical disability.
- • Difficulty in mobility.
About Zeng Changhao
Zeng Changhao is a dedicated clinical trial sponsor focused on advancing medical research and innovation through rigorous and ethically conducted clinical studies. With a commitment to improving patient outcomes, Zeng Changhao collaborates with leading healthcare professionals and research institutions to explore novel therapies and treatment modalities. The organization emphasizes transparency, compliance, and patient safety, ensuring that all trials adhere to the highest regulatory standards. Through its strategic partnerships and a patient-centric approach, Zeng Changhao aims to contribute significantly to the development of effective and safe healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kai Feng, Henan, China
Luoyang, Henan, China
Zhengzhou, Henan, China
Zhengzhou, Henan, China
Zhengzhou, Henan, China
Patients applied
Trial Officials
Sumei Wang, Master
Principal Investigator
Zhengzhou Tielu Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported